Alcohol-induced psychomotor performance impairment in young adult drinkers with alcohol usage disorders

FHS
June 20, 2023
9:34 am

Researchers examined alcohol-induced psychomotor performance impairments among young adult alcohol consumers with alcohol usage disorders (AUDs).

HH-006 by Huahui Health for Hepatitis D: Likelihood of Approval

HH-006 is under clinical development by Huahui Health and currently in Phase I for Hepatitis D.

January 9, 2024

PharmassêtX gains FDA orphan drug status for IBD treatment

The safety and effectiveness of EGCG for IBD were supported by peer-reviewed studies. Credit: MMD Creative/Shutterstock. PharmassêtX has received US Food and Drug Administration’s (FDA)

July 11, 2024

Durable Weight Loss Follows Just a Few Injections of Novel Drug

A once-monthly injectable weight management agent safely induced durable weight loss in a phase I human trial. At the highest dose tested, patients with overweight

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.